<DOC>
	<DOCNO>NCT00934336</DOCNO>
	<brief_summary>The aim study determine whether postprandial hyperglycaemia play important role oxidative stress phenomenon influence harmful effect arterial wall . 25 type 1 diabetic patient practice FIT HbA1c value 8 percent less begin study recruit . The 25 control subject recruit patient , pair age sex . Patients randomized via alternative cross study design 2 period 3 month , i.e . preprandial postprandial injection ultra fast act analog . During 6 month study , slow act analog dos adjust basis basal glycaemia value . The fast acting analog dos adjust basis optimize algorithm available patient 's PDA phone electronic diary . Blood urine sample collect M0 , M3 M6 evaluate stress oxidant grade consequence atherogenesis : Oxidative Stress evaluation : plasma parameter ( lipid peroxide derivative , semicarbazide sensitive oxidase amine activity ) , erythrocyte leukocyte cell parameter ( reduce oxidise glutathion , dismutase superoxide activity ( SOD ) Cu Mn dependent , glutathion peroxidase , catalase ) , urinary parameter ( isoprostane F2 ) Evaluation consequence oxidative stress atherogenesis process : inflammatory parameter ( CRP , TNFa , IL 6 ) , adhesion molecule ( VCAM 1 , ICAM 1 , P selectine ) , adipokines ( leptine , resistine , adiponectine ) , coagulation factor ( PAI 1 ) , platelet endothelial microparticles , The pre postprandial glycaemic stability patient monitor use PDA phone system , HbA1c measure M0 , M3 M6 . Expected result outcome : It important know , patient comparable glycaemic stability , two insulin treatment regimen associate significant difference oxidative stress anti oxidant defense . These result may help u define postprandial insulin treatment regimen ( flexible regard meal ) preprandial insulin treatment regimen ( less flexible meal maybe less harmful term limitation oxidative stress ) .</brief_summary>
	<brief_title>Importance Type 1 Diabetes Patients Optimized Control Post-Prandial Glycaemia Oxidant Stress Prevention</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Type 1 Diabetes treaty basal / bolus ultra rapid analogue pump ultra rapid analogue Adults 18 50 year old Patients practice FIT Written inform consent obtain prior enrollment study HbA1c ≤ 8 % Diabetes DT1 Complications : coronary peripheral arteriopathy Pathologies able interfere study : HTA , dyslipidemia , nicotinism , inflammatory , cancerous pathology… Psychiatric pathology incompatible study Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>